These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 28419968)

  • 1. Current insights into pathogenesis of Parkinson's disease: Approach to mevalonate pathway and protective role of statins.
    Saeedi Saravi SS; Saeedi Saravi SS; Khoshbin K; Dehpour AR
    Biomed Pharmacother; 2017 Jun; 90():724-730. PubMed ID: 28419968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mevalonate Cascade and Neurodevelopmental and Neurodegenerative Diseases: Future Targets for Therapeutic Application.
    Jiao X; Ashtari N; Rahimi-Balaei M; Chen QM; Badbezanchi I; Shojaei S; Marzban A; Mirzaei N; Chung S; Guan T; Li J; Vriend J; Mehr SE; Kong J; Marzban H
    Curr Mol Pharmacol; 2017; 10(2):115-140. PubMed ID: 26758948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The beneficial effects of HMG-CoA reductase inhibitors in the processes of neurodegeneration.
    Saeedi Saravi SS; Saeedi Saravi SS; Arefidoust A; Dehpour AR
    Metab Brain Dis; 2017 Aug; 32(4):949-965. PubMed ID: 28578514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of cholesterol and statins on Parkinson's neuropathology: a narrative review.
    Al-Kuraishy HM; Fahad EH; Al-Windy S; El-Sherbeni SA; Negm WA; Batiha GE
    Inflammopharmacology; 2024 Apr; 32(2):917-925. PubMed ID: 38499742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basic and Clinical Observations of Mevalonate Depletion on the Mevalonate Signaling Pathway.
    Muller AL; Freed DH
    Curr Mol Pharmacol; 2017; 10(1):6-12. PubMed ID: 26758946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Could drugs inhibiting the mevalonate pathway also target cancer stem cells?
    Likus W; Siemianowicz K; Bieńk K; Pakuła M; Pathak H; Dutta C; Wang Q; Shojaei S; Assaraf YG; Ghavami S; Cieślar-Pobuda A; Łos MJ
    Drug Resist Updat; 2016 Mar; 25():13-25. PubMed ID: 27155373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Possible Role for HMG-CoA Reductase Inhibitors and Its Association with
    Pierzchlińska A; Droździk M; Białecka M
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins: multiple neuroprotective mechanisms in neurodegenerative diseases.
    Wang Q; Yan J; Chen X; Li J; Yang Y; Weng J; Deng C; Yenari MA
    Exp Neurol; 2011 Jul; 230(1):27-34. PubMed ID: 20406638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interconnection of Estrogen/Testosterone Metabolism and Mevalonate Pathway in Breast and Prostate Cancers.
    Mokarram P; Alizadeh J; Razban V; Barazeh M; Solomon C; Kavousipour S
    Curr Mol Pharmacol; 2017; 10(2):86-114. PubMed ID: 26758947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Therapeutic Strategies and Perspectives for Neuroprotection in Parkinson's Disease.
    Ghanta MK; Elango P; L V K S B
    Curr Pharm Des; 2020; 26(37):4738-4746. PubMed ID: 32065086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isothiocyanates Are Promising Compounds against Oxidative Stress, Neuroinflammation and Cell Death that May Benefit Neurodegeneration in Parkinson's Disease.
    Sita G; Hrelia P; Tarozzi A; Morroni F
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27598127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent Perspectives.
    Sarkar S; Raymick J; Imam S
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27338353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harnessing the trophic and modulatory potential of statins in a dopaminergic cell line.
    Schmitt M; Dehay B; Bezard E; Garcia-Ladona FJ
    Synapse; 2016 Mar; 70(3):71-86. PubMed ID: 26695835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins induce differentiation and cell death in neurons and astroglia.
    März P; Otten U; Miserez AR
    Glia; 2007 Jan; 55(1):1-12. PubMed ID: 16998865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the Mevalonate Pathway for Treating Esophageal Cancer.
    Wong JVS; Fatehi Hassanabad A
    J Gastrointest Cancer; 2021 Jun; 52(2):819-821. PubMed ID: 33931828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The balance between induction and inhibition of mevalonate pathway regulates cancer suppression by statins: A review of molecular mechanisms.
    Ahmadi Y; Ghorbanihaghjo A; Argani H
    Chem Biol Interact; 2017 Aug; 273():273-285. PubMed ID: 28668359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins.
    Iannelli F; Lombardi R; Milone MR; Pucci B; De Rienzo S; Budillon A; Bruzzese F
    Recent Pat Anticancer Drug Discov; 2018; 13(2):184-200. PubMed ID: 29189178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins: mechanisms of neuroprotection.
    van der Most PJ; Dolga AM; Nijholt IM; Luiten PG; Eisel UL
    Prog Neurobiol; 2009 May; 88(1):64-75. PubMed ID: 19428962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of different inflammatory diseases by impacting the mevalonate pathway.
    Zeiser R; Maas K; Youssef S; Dürr C; Steinman L; Negrin RS
    Immunology; 2009 May; 127(1):18-25. PubMed ID: 19191903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.